EVMN Form 144: 15,000-Share Resale Listed

EVMN: Notice of proposed resale of Common Stock under Rule 144 The excerpt lists proposed sales of Common Stock including 15,000 shares tied to an exercise of stock options with a sale date of 06/01/2026.

Rhea-AI Filing Summary

EVMN: Notice of proposed resale of Common Stock under Rule 144

The excerpt lists proposed sales of Common Stock including 15,000 shares tied to an exercise of stock options with a sale date of 06/01/2026. It also shows 3,175 shares from a Pre-IPO Purchase dated 04/26/2026. The filer is identified as Morgan Stanley Smith Barney LLC Executive Financial Services on behalf of the seller.

Key Figures

Filed resale via option exercise: 15,000 shares Pre-IPO purchase listed: 3,175 shares

2 metrics

Filed resale via option exercise 15,000 shares Exercise of Stock Options dated 06/01/2026

Pre-IPO purchase listed 3,175 shares Pre-IPO Purchase of Common Shares dated 04/26/2026

Key Terms

Form 144, Exercise of Stock Options, Pre-IPO Purchase

3 terms

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Stock Options financial

"Securities To Be Sold | Exercise of Stock Options"

Pre-IPO Purchase financial

"Pre-IPO Purchase of Common Shares | 04/26/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the EVMN Form 144 filing report?

The filing reports proposed resale of Common Stock under Rule 144, including 15,000 shares from an option exercise dated 06/01/2026. It also lists 3,175 shares from a pre-IPO purchase dated 04/26/2026.

Who is listed as the filer on the EVMN excerpt?

The excerpt identifies Morgan Stanley Smith Barney LLC Executive Financial Services as the filer. The entry includes an address at 1 New York Plaza, 8th Floor in New York, NY as the filer contact.

What transaction types are disclosed for the shares in the excerpt?

The excerpt shows two transaction types: an exercise of stock options tied to 15,000 shares and a Pre-IPO Purchase of Common Shares tied to 3,175 shares, with the respective dates shown in the excerpt.

When are the proposed sales dated in the excerpt?

The exercise-related resale is dated 06/01/2026 for 15,000 shares. The pre-IPO purchase entry is dated 04/26/2026 for 3,175 shares, as shown in the excerpt.

Does the excerpt state how the sales will be conducted or proceeds used?

The excerpt indicates the exercise transaction is labeled Cash, but it does not provide further details on distribution methods or use of proceeds in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 04:46 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002092017
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Evommune, Inc.
SEC File Number	001-42938
Address of Issuer	1891 Page Mill Road Palo Alto CALIFORNIA 94304
Phone	925-247-4481
Name of Person for Whose Account the Securities are To Be Sold	JEEGAR PATEL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	18175	422205.25	36018372	06/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2026	Exercise of Stock Options	Issuer			15000	06/01/2026	Cash
Common	04/26/2023	Pre-IPO Purchase of Common Shares	Issuer			3175	04/26/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	06/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jeegar Pravinkumar Patel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)